Navigation Links
Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
Date:7/13/2014

Columbus, OH (PRWEB) July 13, 2014

A Xarelto lawsuit webpage has been launched by Wright & Schulte LLC to provide consumers with the most current information regarding serious internal bleeding that can sometimes accompany use of the blood-thinning medication, as well as the growing number of Xarelto bleeding lawsuits pending in courts around the country. The law firm is now offering free legal evaluations to anyone who may have suffered from life-threatening internal bleeding and related complications while using Xarelto, including:

  •     Gastrointestinal Bleeding
  •     Cerebral Hemorrhage
  •     Heart Attack
  •     Stroke
  •     Blood Clots
  •     Death

Xarelto is a blood thinner that is used for a number of indications, including the prevention of blood clots related to atrial fibrillation, and the treatment of dangerous blood clots called deep vein thrombosis and pulmonary embolism. It is also given to patients who have just had hip or knee replacement surgery to reduce the risk of blood clots in the legs and lungs. Xarelto was approved by the U.S. Food & Drug Administration (FDA) in 2011, and is manufactured by Bayer HealthCare. Janssen Pharmaceutical, a division of Johnson & Johnson, markets Xarelto in the U.S.
(fda.gov/downloads/Drugs/DrugSafety/
UCM280333.pdf, FDA, March 2014)

All blood thinners, including Xarelto, can cause patients to suffer internal hemorrhaging. However, there currently exists no antidote to reverse Xarelto bleeding. Since its approval, the drug has been the subject of several FDA safety alerts. In August 2013, a boxed warning was added to the Xarelto label advising that premature discontinuation of the drug increases the risk of thrombotic events. The FDA also warned that epidural or spinal hematomas with the potential to cause long-term or permanent paralysis could occur in Xarelto patients who receive anesthesia or undergo spinal puncture.
(fda.gov/safety/medwatch/safetyinformation/ucm367392.htm, FDA, March 2014)

According to a report published by Reuters last month, at least 10 Xarelto lawsuit claims have been filed in U.S. courts on behalf of patients who may have been injured by the blood thinner. Most recently, a Florida woman filed a wrongful death lawsuit on behalf of her husband, who allegedly died due to uncontrollable bleeding caused by Xarelto. Among other things, the complaint, which was filed on June 23, 2014 in U.S. District Court, Southern District of Florida, claims that the manufacturers of Xarelto failed to warn that there was no reversal agent for Xarelto bleeding. The lawsuit further alleges that Xarelto is unreasonably dangerous and defective, and points out that safer alternatives exist, such as warfarin, which have reversal agents for internal bleeding. (Case 0:14-cv-61448-JAL)
(reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614, June 14, 2014)

The attorneys of Wright & Schulte LLC believe that additional Xarelto lawsuits involving similar allegations will be filed against the manufacturers of this medication in the coming months. The Firm is offering free, no-obligation legal reviews to anyone who suffered serious internal bleeding and related complications due to their use of Xarelto. To learn more, or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Xarelto lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/07/prweb12013070.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
2. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure
3. DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant
4. Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns
5. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing
6. Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators
7. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
8. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal C.R. Bard Litigation
9. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
10. Best Transvaginal Mesh Attorneys? LawsuitLegal.com Now Accepting Surgical Mesh Failure Victim Inquiries
11. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Recall Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: